Code |
EPMT |
Title |
PT. Enseval Putera Megatrading Tbk |
Address |
|
Background |
The scope of its activities consists of trading, transportation, industry, representative, and/or agency and forwarding. Until 1998, the company is mainly engaged in the distribution and supply of pharmaceutical and consumer products, cosmetics and other products with 26 branches throughout Indonesia. |
Business cp product |
The scope of its activities consists of trading, transportation, industry, representative, and/or agency and forwarding. Until 1998, the company is mainly engaged in the distribution and supply of pharmaceutical and consumer products, cosmetics and other products with 26 branches throughout Indonesia. |
Subsidiary affiliation |
Subsidiaries | Domicile | Business | % | PT Tri Sapta Jaya | Indonesia | Distribution of pharmaceutical products and medical equipment | 99.99 | PT Millenia Dharma Insani | Indonesia | Pharmacy, trading of pharmaceutical products and health care clinics | 100 | PT Enseval Medika Prima | Indonesia | Distribution of medical equipments | 100 | PT Global Chemindo Megatrading | Indonesia | Trading of raw materials for pharmaceutical products | 100 | PT Renalmed Tiara Utama | Indonesia | Distribution of medical supplies | 98.75 | PT Medika Renal Citraprima | Indonesia | Hemodialysis clinic, trading of consumable product for hemodialysis theraphy | 100 | PT Global Karsa Medika | Indonesia | Wholesale trading of pharmaceutical, medical equipment, food and beverage | 100 | PT Forsta Kalmedic Global | Indonesia | Medical equipment industry, dental equipment, other equipment and calibration services | 100 | PT Emos Global Digital | Indonesia | Trading and business information services through web portals and or digital platforms | 55 |
|
Commissioners |
President Commissioner | : Bernadus Karmin Winata | | Commissioner | : Sanadi Boenjamin | | Commissioner | : Djonny Hartono Tjahyadi | | Independent Commissioner | Lucky Surjadi Slamet | | Independent Commissioner | Pre Agusta Suswantoro | | | | | | | | Per 30 Sep 2023 | | |
|
Directors |
President Director | : Jos Iwan Atmadjaja | | Director | : Budiyanto Bambang | | Director | : Stanley Handiono Angkasa | | Director | : Phing Phing Lienana Kusmiantoro | | | | | Per 30 Sep 2023 | | |
|
Underwriter |
|
Share registrar |
PT. Adimitra Transferindo | | | |
Share holders |
Shareholders | Shares | % | | | PT. Kalbe Farma Tbk | 2504801795 | 92.47 | | | Public (< 5%) | 203838205 | 7.53 | | | | | | | | As of Sep 30, 2023 | | | | |
|
History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp. 5,50008-Jan-199410001200000060000000 9:10 Bonus Issue13-Jun-1995100054000000114000000 Stock Split29-Sep-1997500114000000228000000 Stock Split13-Sep-1999250228000000456000000 Stock Split 1:511-Dec-20035018240000002280000000 Additional Share HMETD28-Mar-20112504286400002708640000
|
Other infos |
At present, PT Enseval Putera Megatrading Tbk, has 30 branches troughout Indonesia, from Banda Aceh to Jayapura. Branches are generally found in each province. The target to be achieved now is to increase the number of branches to 40, and to have them located not only in each province but also the regency level. |
Created date |
2023-11-09 11:08:44 |
Revised date |
2023-11-09 11:08:44 |
Finance |
PT. Enseval Putera Megatrading Tbk |
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015,
2014,
2013,
Financial Statetment Date |
Fiscal Year Ends |
Months Covered in Income St |
|
Summary Covered in Income St |
Cash and Cash Equivalents |
Receivables |
Inventories |
Current Assets |
Fixed Assets |
Other Assets |
Non Current Assets |
Total Assets |
Current Liabilities |
Longterm Liabilities |
Total Liabilities |
Authorized |
Paid-up Capital |
Par Value |
Paid-up Capital Shares |
Retained Earnings |
Total Equity |
Minority Interest |
|
Summary of Income Statement |
Total Sales |
Cost of Good Sold |
Gross Profit |
Operating Profit |
Other Income |
Earning Before Tax |
Tax |
Net Income |
Close Price |
|
Per Share Data (Rp) |
Eps (annualized) |
Book Value |
|
Financial Ratios |
Debt Equity Ratio (X) |
Roa(%) |
Roe(%) |
Npm(%) |
Opm(%) |
Gross Profit Margin (%) |
Total Assets Turnover |
|
Cash Flow |
CF from Operation Activities |
CF from Investing Activities |
CF from Financing Activities |
Net Increase in Cash & Cash Equivalent |
Cash & Cash Equivalent at Beginning of the Year |
Cash & Cash Equivalent at The End of the Year |
|
|